Trial intelligence / Profile preview

Zileuton Injection in Asthma

NCT00299065Phase 2Completed

Sponsor
Critical Therapeutics, Inc.
Start
Jan 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of zileuton extended release in asthma, sponsored by Critical Therapeutics, Inc.. Started Jan 2006; status: completed.

02

Drugs

zileuton extended release
03

Conditions

asthma

Beyond the preview

Go deeper on NCT00299065.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00299065.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call